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Prognostic role of carotid intima-
media thickness in off-pump 
coronary artery bypass surgery
Sung-Yeon Ham  1, Jong-Wook Song1,2,3, Jae-Kwang Shim1,2,3, Sarah Soh1,2,3, Hee-Jung Kim1 
& Young-Lan Kwak1,2,3
Carotid intima-media thickness (IMT) is a well-known predictor of adverse outcomes in the ischemic 
heart disease patients; however, evidence is lacking in patients undergoing off-pump coronary artery 
bypass surgery (OPCAB). Data from 407 patients who underwent OPCAB between April 2013 and 
August 2016 were retrospectively reviewed. A composite of cardiovascular morbidity endpoints 
was defined as the presence of stroke, acute myocardial infarction, new cardiac arrhythmia (newly 
developed atrial fibrillation, atrial flutter, or atrioventricular block), cardiovascular death, or 
cerebrovascular death within 30 days after surgery. Increased carotid IMT was defined as ≥0.9 mm on 
one or both sides. The incidence of a composite of cardiovascular morbidity endpoints was 24.0% in the 
normal IMT group (n = 221) and 34.4% in the increased IMT group (n = 186) (p = 0.021). Multivariable 
analysis revealed increased IMT (odds ratio 1.719, 95% confidence interval 1.108 to 2.666, p = 0.016) 
and preoperative renal replacement therapy (odds ratio 4.264, 95% confidence interval 1.679 to 10.829, 
p = 0.002) as independent predictors of a composite of cardiovascular morbidity endpoints. In patients 
undergoing OPCAB, preoperative assessment of carotid IMT may help predicting the development of a 
postoperative composite of cardiovascular morbidity endpoints.
The development of intimal thickening has been demonstrated to create a substrate for atherosclerotic stimuli, predis-
posing the artery to the development of advanced atherosclerosis1,2. In conjunction, carotid intima-media thickness 
(IMT) is being considered a preclinical surrogate marker reflecting atherosclerotic burden, endothelial dysfunction, 
and target organ damage3–5. Indeed, ample evidence is available supporting the role of carotid IMT as a strong predic-
tor of cardiovascular outcomes in nonsurgical populations of either asymptomatic or diseased patients5,6. Moreover, 
its predictive role extends to patients with ischemic heart disease undergoing percutaneous coronary intervention 
(PCI), who have advanced atherosclerosis that has progressed far beyond the preclinical stage7.
In addition, patients undergoing coronary artery bypass graft (CABG) surgery are at a high risk of developing 
adverse cardiovascular outcomes. Accordingly, risk prediction models utilizing traditional risk factors have been 
proposed by responsible societies in an effort to improve risk evaluation and outcome8–10. However, the accuracies 
of the two most widely used risk models (European System for Cardiac Operative Risk Evaluation [EuroSCORE] 
and the Society of Thoracic Surgeons Risk Score) are subject to debate8,10–12, and they do not incorporate param-
eters for directly assessing the patient’s vascular status, such as IMT. Yet, in contrast to the encouraging results 
in the PCI setting7, the prognostic value of carotid IMT could not be observed in patients undergoing on-pump 
CABG13.
Off-pump CABG (OPCAB) serves as an important technique for surgical revascularization, which may be 
preferred in patients with cerebrovascular risk factors14 and in elderly patients15. Theoretically, it imposes the addi-
tional burden of surgery on coronary artery disease and PCI, yet avoids risks related to cardiopulmonary bypass 
(CPB). Therefore, the predictive role of carotid IMT on a composite of cardiovascular morbidity endpoints after 
OPCAB may be different from those after PCI or on-pump CABG; however, this has not been addressed before.
In this retrospective study, we tested our hypothesis that preoperatively evaluated carotid IMT could be a 
meaningful predictor of a composite of cardiovascular morbidity endpoints after OPCAB.
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Materials and Methods
After receiving approval from the Institutional Review Board of Severance Hospital (4-2015-1002), we retro-
spectively reviewed the medical records of adult patients who underwent isolated OPCAB at the Cardiovascular 
Hospital of Yonsei University Health System between April 2013 and August 2016. The need for informed consent 
was waived. During the study period, a total of 702 consecutive patients underwent OPCAB. Patients who under-
went cardiopulmonary bypass during the surgery (n = 1), emergency surgery (n = 34), and without carotid IMT 
assessment within 1 month before surgery (n = 205) were excluded. Among patients assessed with carotid IMT, 
patients with internal carotid artery stenosis >50% were also excluded (n = 55) due to the lack of feasibility to 
measure carotid IMT accurately and well-known high risk of postoperative neurologic complications. A total of 
407 patients were enrolled in the current study, and divided into the normal IMT group (n = 221) and increased 
IMT group (n = 186) (Fig. 1). Increased carotid IMT was defined as carotid IMT ≥ 0.9 mm on one or both sides.
Study end points. The primary end point was to compare the incidence of a 30-day composite of cardiovas-
cular morbidity endpoints after OPCAB between the groups and to investigate whether increased carotid IMT 
is an independent risk factor for developing a composite of cardiovascular morbidity endpoints. A composite of 
cardiovascular morbidity endpoints was defined as the presence of stroke, acute myocardial infarction (creatinine 
kinase-MB > 25 ng/mL, newly developed Q wave on electrocardiography, or development of left bundle branch 
block), new cardiac arrhythmia (newly developed postoperative atrial fibrillation, atrial flutter, or atrioventricular 
block), or cardiovascular or cerebrovascular death within 30 days after OPCAB. Based on the prognostic impor-
tance of postoperative new cardiac arrhythmia in cardiac surgical patients16,17 and the close relationship between 
the increased carotid IMT and the occurrence of atrial fibrillation in medical patients18–20, we included new car-
diac arrhythmia in the composite of cardiovascular morbidity end points.
Carotid ultrasonography. The carotid IMT was assessed with high-resolution B-mode ultrasonography, 
with an 11-MHz imaging transducer (Vivid-7, Vivid E9 [GE, Milwaukee, WI, USA], SC2000 [Siemens, Mountain 
View, CA, USA], and Sonos 7500 or iE33 [Philips, Andover, MA, USA]). Ultrasonographic images of the carotid 
artery were acquired in end-diastolic phase. Carotid IMT was measured at the far vessel wall at a site approxi-
mately 1 cm proximal to the carotid bulb. All ultrasonographic measurements were performed by sonographers 
certified by the Registry of Diagnostic Cardiac Sonographers.
Preoperative measurements. The investigated baseline patient characteristics were sex; age; body surface 
area; history of diabetes, hypertension, cerebrovascular accident, and chronic kidney disease; left ventricular 
ejection fraction; extent of coronary artery disease; and EuroSCORE II8,10.
Intraoperative management and measurement. Standardized anesthetic care according to an insti-
tutional protocol was provided to all patients. On transfer to the operating room, five-lead electrocardiography, 
pulse oximetry, and invasive arterial blood pressure monitoring were conducted. Anesthesia was induced with 
midazolam 0.03–0.05 mg/kg and sufentanil 1.5–2 μg/kg. Tracheal intubation was facilitated with rocuronium 
bromide 50 mg. Patients were ventilated with 40% oxygen, tidal volume of 8 mL/kg, respiratory rate of 8–14/
min, and positive end-expiratory pressure of 5 mm Hg. Anesthesia was maintained with 0.6–2.0 vol% of sevo-
flurane and sufentanil 0.5–1.5 μg·kg−1·h−1. Transesophageal echocardiography (TEE) was performed to evalu-
ate cardiac function, to detect newly developed regional wall motion abnormality or mitral regurgitation, and 
to record the Katz grade (Grade 1 = normal to mild intimal thickening, Grade 2 = severe intimal thickening, 
Grade 3 = atheromas protruding <5 mm into the aortic lumen, Grade 4 = atheromas protruding ≥5 mm into 
the aortic lumen, Grade 5 = with mobile components)21. A pulmonary artery catheter was inserted to monitor 
cardiac output and pulmonary arterial pressure. Intraoperatively, balanced crystalloid (Plasma solution A 1000 
inj; CJ, Seoul, Korea) was infused at 5–6 mL·kg−1·h−1, and balanced synthetic colloid (Volulyte; Fresenius Kabi, 
Bad Homburg, Germany) was used to replace estimated blood loss at a maximum dose of 1000 mL. A cell-saving 
Figure 1. Study flowchart. ICA, internal carotid artery; IMT, intima-media thickness; OPCAB, off-pump 
coronary bypass surgery.
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device was used, and collected blood was reinfused at the end of the operation. Mean arterial pressure (MAP) was 
maintained at >70 mm Hg with norepinephrine infusion and 5–10° Trendelenburg position during grafting. If 
the norepinephrine infusion dose was >0.2 µg·kg−1·min−1 to achieve the target MAP, vasopressin (up to 4 IU/h) 
was added in a stepwise fashion. Milrinone (0.5 µg·kg−1·min−1) was infused if mixed venous oxygen saturation 
was persistently low (SvO2, <60% for >10 min) or severe mitral regurgitation (grade ≥ 3) was newly developed. 
Allogeneic packed erythrocytes (pRBCs) were transfused when the hematocrit decreased to <25% throughout 
the study period.
The number of grafts performed; duration of anesthesia and operation; amounts of vasopressors and ino-
tropics; hemodynamics including heart rate, MAP, cardiac index, and mixed venous oxygen saturation (SvO2); 
amount of intraoperative fluid administration and urine output; and amount of reinfused blood via cell salvage 
and pRBC transfusion were recorded. All patients were transported to the intensive care unit (ICU) after the 
operation.
Postoperative measurements. The amount of blood loss and transfusion within postoperative 24 hours, 
and the lengths of ICU and hospital stay were recorded postoperatively.
Statistical analysis. All statistical analyses were performed with SPSS 23.0 (IBM Corp. Released 2015. IBM 
SPSS Statistics for Windows, Version 23.0. Armonk, NY: IBM Corp). For continuous variables, descriptive sta-
tistical values were calculated and reported as mean ± standard deviation. Categorical variables were described 
by using frequency distributions. Student’s t-test or the Mann-Whitney U-test were used to detect differences in 
the mean of continuous variables, and the chi-square test or Fisher’s exact test was used to compare categorical 
variables between Normal IMT group and Increased IMT group. Because age at operation differed between the 
groups, multiple linear regression analysis was performed. Logistic regression analysis was conducted to investi-
gate independent risk factors for composite of cardiovascular morbidity endpoints after OPCAB. To evaluate pos-
sible risk factors for composite of cardiovascular morbidity endpoints, a univariable logistic regression analysis 
was performed. For the multivariable model, a stepwise selection method was used to select variables that showed 
p < 0.05 in the univariable analysis. A value of p < 0.05 was considered statistically significant.
Results
During the study period, a total of 407 patients were retrospectively identified. Of them, 221 patients exhibited 
normal carotid IMT (<0.9 mm), whereas the remaining 186 patients exhibited increased carotid IMT (≥0.9 mm) 
(Fig. 1).
There were no significant differences between the groups in baseline characteristics including preoperative 
medications and the severity of coronary disease, except age. Patients in the increased IMT group were older than 
those in the normal IMT group (66.3 ± 8.4 years vs. 62.2 ± 9.8 years, p < 0.001). Katz grade (3.7 ± 0.7 vs. 3.4 ± 0.8, 
p < 0.001) investigated with intraoperative TEE and the incidence of Katz grade ≥ 4 (62.9% vs. 46.2%, p = 0.001) 
were both significantly higher in the increased IMT group than in the normal IMT group (Table 1).
The incidence of a 30-day composite of cardiovascular morbidity endpoints (34.4% vs. 24.0%, p = 0.021) was 
significantly greater in the increased IMT group than in the normal IMT group. The incidence of 30-day all-cause 
mortality (normal IMT; 1.4% vs. increased IMT; 2.7%, p = 0.478), and the lengths of ICU and hospital stay and 
were similar between the groups (Table 2).
Intraoperative data including the number of grafts performed, fluid balance, and transfusion requirement 
were similar between the groups. The total amount of norepinephrine infused during the operation was signifi-
cantly greater in the increased IMT group than in the normal IMT group (909.0 ± 598.9 μg vs. 736.2 ± 543.8 μg, 
p = 0.029). The number of patients who required vasopressin was also significantly greater in the increased IMT 
group than in the normal IMT group (57.7% vs. 44.6%, p = 0.017). Intraoperative hemodynamics (data not 
shown) including the lowest cardiac index and SvO2 were similar between the groups (Table 3).
Among the variables assessed in the univariable analysis, increased IMT, age, and preoperative renal replace-
ment therapy (RRT) showed p < 0.05, and were further introduced into multivariable analysis. In multivariable 
logistic regression analysis to detect independent factors of a composite of cardiovascular morbidity endpoints 
after OPCAB, increased IMT (odds ratio 1.719, 95% confidence interval 1.108 to 2.666, p = 0.016) and preoper-
ative RRT (odds ratio 4.264, 95% confidence interval 1.679 to 10.829, p = 0.002) remained as independent risk 
factors for 30-day composite of cardiovascular morbidity endpoints (Table 4).
Discussion
In this retrospective study addressing the impact of preoperative carotid IMT on postoperative outcome in 
OPCAB, we observed a significantly more frequent occurrence of a 30-day composite of cardiovascular morbid-
ity endpoints in the increased IMT (≥0.9 mm) group than in the normal IMT group. Moreover, only increased 
carotid IMT was revealed to be independently associated with a 1.7-fold increase in the risk of developing a 
30-day composite of cardiovascular morbidity endpoints along with preoperative requirement for RRT, which 
showed a 4.3-fold increased risk.
In the management of patients undergoing cardiac surgery, the importance of risk scores for identify-
ing high-risk patients is widely appreciated not only for accurate risk stratification but also for the application 
of potentially beneficial preventive strategies in order to improve prognosis. Currently, most of the validated 
risk scoring systems are based on combinations of traditional risk factors that mainly reflect the preoperative 
co-morbid disease status and functional capacity of the patients, and factors related to the specific risk inherent to 
the type of surgery11,12. With particular attention to patients undergoing CABG surgery, distinct efforts have been 
made to predict postoperative morbidity more accurately by including the vascular status of the patient. Among 
them, the presence of protruding atheroma investigated with TEE has been shown to be an important risk factor 
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for perioperative stroke in patients undergoing CABG22. TEE is an invaluable monitoring tool during CABG; 
however, it is a relatively invasive method and not routinely performed preoperatively in patients requiring iso-
lated CABG. Thus, a noninvasive, simple, and preoperatively feasible method such as carotid ultrasonography has 
been proposed as a screening test for cardiovascular events.
Among parameters measured with carotid ultrasonography, IMT measured with B-mode ultrasound reflects 
the process of arterial wall change in association with atherosclerosis as a continuous variable1. Carotid IMT 
has been used as an indicator of generalized vascular atherosclerosis and arterial aging3, as well as an index to 
predict the degree of atherosclerosis of the coronary arteries23. In medical patients, increase in carotid IMT was 
closely associated with increases of the relative risks for stroke and myocardial infarction in long-term follow-up 
Normal IMT (n = 221) Increased IMT (n = 186) p value
Sex (female) 41 (18.6) 32 (17.2) 0.724
Age (years) 62.2 ± 9.8 66.3 ± 8.4 <0.001*
BSA (m2) 1.8 ± 0.2 1.7 ± 0.2 0.645
DM 125 (56.6) 104 (55.9) 0.896
HTN 149 (67.4) 134 (72.0) 0.313
CVA 18 (8.1) 21 (11.3) 0.283
CKD/preoperative RRT 35 (15.8)/12 (5.4) 25 (13.4)/8 (4.3) 0.497/0.600
EF (%) 55.4 ± 13.9 53.3 ± 15.3 0.158
Left main disease 49 (22.2) 52 (28.1) 0.176
Number of graft 3.4 ± 0.8 3.3 ± 0.8 0.800
Number of diseased vessels 2.9 ± 0.4 2.9 ± 0.3 0.989
   1 vessel disease 1 (0.5) 0 1.000
   2 vessel disease 29 (13.1) 26 (14.0) 0.884
   3 vessel disease 191 (86.4) 160 (86.0) 1.000
Unstable angina 126 (57.0) 98 (52.7) 0.355
MI within 1 week 39 (17.7) 35 (18.8) 0.777
NYHA III or IV 24 (10.9) 28 (15.1) 0.221
EuroSCORE II 4.1 ± 2.8 4.7 ± 2.7 0.051
Beta blocker 119 (53.8) 92 (49.5) 0.426
RAS antagonists 96 (43.4) 92 (49.5) 0.233
Statin 169 (76.5) 141 (75.8) 0.907
Katz grade/grade ≥ 4 3.4 ± 0.8/102 (46.2) 3.7 ± 0.7/117 (62.9) <0.001*/0.001*
Preoperative CK-MB (μg/L) 2.5 ± 4.6 3.2 ± 10.8 0.405
Preoperative Cr (mg/dL)/eGFR 1.3 ± 1.8/80.8 ± 25.9 1.2 ± 1.2/79.9 ± 23.2 0.208/0.691
Table 1. Demographic and perioperative clinical data. Values are presented as the mean ± standard deviation 
or number of patients (%). *p < 0.05. BSA, body surface area; CKD, chronic kidney disease; CK-MB, serum 
creatinine kinase-MB level; Cr, serum creatinine level; CVA, cerebrovascular accident; DM, diabetes mellitus; 
EF, ejection fraction; eGFR (mL·min−1·1.73 m−2), estimated glomerular filtration rate; EuroSCORE II, 
European System for Cardiac Operative Risk Evaluation II; HTN, hypertension; left main disease, left main 
coronary artery stenosis >50%; MI, myocardial infarction; NYHA, New York Heart Association Functional 
Classification; RAS, renin-angiotensin system; RRT, renal replacement therapy.
Normal IMT 
(n = 221)
Increased IMT 
(n = 186) p value
30 d composite of cardiovascular 
morbidity endpoints 53 (24.0%) 64 (34.4%) 0.021*
   Postop stroke 2 (0.9%) 4 (2.2%) 0.419
   Postop MI 8 (3.6%) 9 (4.8%) 0.540
   Postop arrhythmia 41 (18.6%) 47 (25.3%) 0.101
   Cardiovascular mortality 2 (0.9%) 4 (2.2%) 0.419
   Cerebrovascular mortality 0 0 N/A
30 d-all cause mortality 3 (1.4%) 5 (2.7%) 0.478
ICU day (day) 2.9 ± 3.1 2.9 ± 2.6 0.991
Hospital day (day) 14.4 ± 12.3 14.1 ± 8.5 0.773
Table 2. Postoperative outcomes. Values are presented as the mean ± standard deviation or number of patients 
(%). *p < 0.05. MI, myocardial infarction; Postop arrhythmia, newly developed postoperative atrial fibrillation, 
atrial flutter, or atrioventricular block; 30 d-all cause mortality, mortality with any cause within postoperative 30 
days; ICU, intensive care unit.
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studies5,6,24,25, and was a strong predictor of cardiovascular events5, even in patients without known cardiovascular 
disease26. Recent studies also revealed that increased carotid IMT can also predict the occurrence of atrial fibril-
lation in various medical cohorts19,20,27. This association was suggested to be attributable to atrial hypoperfusion 
and ischemia caused by arterial structural change28, while postoperative arrhythmia is a well-known harbinger of 
adverse outcome, especially after CABG16. These findings proved the importance of carotid IMT as a surrogate 
end point for atherosclerosis and target organ damage3. Furthermore, in a previous study, decrease in carotid IMT 
with treatment strategies resulted in the reduction of vascular events29, indicating that carotid IMT would be a 
validated marker for the reversibility of atherosclerosis and serve as a guide for therapies3. Despite its solid back-
ground in medical patients, only a dearth of researches have evaluated the validity of carotid IMT as a predictor 
of postoperative cardiovascular outcome in patients undergoing CABG.
Notably, by avoiding CPB, OPCAB should possess distinct characteristic features of reduced systemic athero-
sclerotic embolic burden30. On the other hand, inevitable hemodynamic derangements and reduction in cardiac 
output during distal anastomosis may elicit organ damage, especially when endothelial dysfunction is present. 
Moreover, compliance of the vascular system assessed at the carotid artery has been shown to be closely related to 
the degree of hemodynamic compromise during grafting in OPCAB, possibly owing to vascular-ventricular cou-
pling31. Therefore, preoperative vascular status as assessed by using carotid IMT would have clinical relevance in 
predicting a composite of cardiovascular morbidity endpoints after OPCAB, which has not been validated before. 
The reported benefits and related preference for OPCAB in elderly patients15 and in certain groups of high-risk 
patients for cerebrovascular events32 also add to the importance of vascular status as a predictor of a composite of 
cardiovascular morbidity endpoints after OPCAB.
Normal IMT 
(n = 221)
Increased IMT 
(n = 186) p value
Graft number 3.4 ± 0.8 3.3 ± 0.8 0.800
Anesthesia time (min) 304.7 ± 39.5 309.8 ± 38.6 0.190
Operative time (min) 232.4 ± 39.4 237.9 ± 47.5 0.198
Total ischemic time (min) 36.5 ± 9.3 35.6 ± 8.3 0.366
Amount of crystalloid (mL) 1698.2 ± 642.3 1764.1 ± 543.9 0.279
Amount of colloid (ml) 478.4 ± 244.5 492.4 ± 201.4 0.538
Urine output (ml) 300.2 ± 224.2 338.5 ± 272.4 0.127
pRBC transfusion (ml) 64.5 ± 161.9 65.8 ± 144.8 0.928
Cell saver (ml) 253.7 ± 149.3 251.5 ± 134.5 0.883
Patients with norepinephrine 178 (99.4%) 152 (99.3%) 1.000
Total norepinephrine (mcg) 736.2 ± 543.8 909.0 ± 598.9 0.029*
Patients with vasopressin 79 (44.6%) 90 (57.7%) 0.017*
Patients with milrinone 23 (13.0%) 21 (13.5%) 1.000
Lowest cardiac index (L/m2) 1.6 ± 0.3 1.7 ± 0.4 0.367
Lowest SvO2 (%) 70.6 ± 7.8 69.8 ± 7.6 0.586
Bleeding for postop 24 h (ml) 681.2 ± 462.4 646.5 ± 373.0 0.407
pRBC transfusion for postop 24 hrs (ml) 112.8 ± 224.9 88.8 ± 181.5 0.240
Table 3. Operation related data. Values are presented as the mean ± standard deviation or number of patients 
(%). Cell saver, amount of reinfused blood by the cell salvage technique; SvO2, mixed venous oxygen saturation; 
pRBC, packed red blood cell.
Univariable Multivariable
OR (CI) p value OR (CI) p value
Increased IMT 1.741 (1.081–2.807) 0.023* 1.719 (1.108–2.666) 0.016*
Age 1.012 (0.983–1.043) 0.423
DM 0.777 (0.486–1.243) 0.292
HTN 1.372 (0.793–2.374) 0.259
CVA 1.304 (0.613–2.774) 0.491
Preoperative RRT 4.178 (1.466–11.911) 0.007* 4.264 (1.679–10.829) 0.002*
Recent MI 0.941 (0.497–1.782) 0.851
Katz grade ≥ 4 1.077 (0.650–1.783) 0.774
EuroSCORE II 1.012 (0.918–1.116) 0.811
Table 4. Logistic regression analysis for predictors of 30-day composite of cardiovascular morbidity 
endpoints. Values are presented as the odds ratio (95% confidential interval). *p < 0.05. Increased IMT, carotid 
intima-media thickness ≥0.9 mm on one or both sides; DM, diabetes mellitus; HTN, hypertension; CVA, 
cerebrovascular accident; RRT, renal replacement therapy; Recent MI, myocardial infarction within 1 wk; 
EuroSCORE II, European System for Cardiac Operative Risk Evaluation II.
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As our results indicate, increased IMT of ≥0.9 mm at any one of the carotid arteries was an independent prog-
nostic factor for a 30-day composite of cardiovascular morbidity endpoints after OPCAB along with preoperative 
RRT, whereas the EuroSCORE II was similar between the normal IMT and increased IMT groups. This finding is 
in accordance with the previous result in patients undergoing vascular surgery that delineated prognostic values 
of increased carotid IMT to predict cardiovascular events and mortality33. In patients with coronary artery dis-
ease, the prognostic value of increased carotid IMT for cardiovascular events could be proven in patients under-
going PCI7; however, a study conducted in patients undergoing on-pump CABG could not prove it13, contrary to 
the results of the current study. This discrepancy might be primarily associated with the use of CPB. By excluding 
the impact of systemic embolic atheromatous burden by large aortic cannulas, mechanically driven flow, and 
cross clamps34, increased carotid IMT, as a reflection of the indwelling vascular status itself, may have played a 
more decisive role on the occurrence of a composite of cardiovascular morbidity endpoints after OPCAB, which 
is consistent with the PCI setting7. In that context, Katz grade, a definite risk factor for cardiovascular events in 
on-pump CABG, was not an independent risk factor for a composite of cardiovascular morbidity endpoints in the 
present study, although the number of patients with Katz grade ≥4 were significantly greater in the increased IMT 
group. Since the incidence of adverse outcome following coronary revascularization surgery was demonstrated 
to be different between OPCAB and on-pump CABG15,32 and possible etiologies might be different due to factors 
including the use of CPB, the risk stratification method should be individualized according to the method of the 
surgery. In this regard, the strength of this study was to examine the risk assessment tool in patients with OPCAB 
who differ from on-pump CABG patients.
We also observed a significantly higher vasopressor requirement in the increased IMT group than in the nor-
mal IMT group during the operation in order to maintain the preset target MAP. This might also be attributed 
to reduced vascular compliance31 and increased blood pressure variability35,36, which are characteristic features 
of patients with increased carotid IMT. Increased blood pressure variability was reported to markedly contribute 
to the increased risk of cardiovascular events in nonsurgical patients with increased carotid IMT, supporting the 
close relationship between the vasopressor requirement and carotid IMT.
The finding that age, a previously well-known risk factor of adverse outcome after OPCAB10, could no longer be 
identified as an independent risk factor of a composite of cardiovascular morbidity endpoints after multivariable anal-
ysis may be attributable to its close relationship with carotid IMT37. Accordingly, our results also show that patients 
in the increased IMT group were significantly older than those in the normal IMT group. Thus, the interdependence 
of these variables may have caused the exclusion of age as a risk factor, whereas increased carotid IMT more directly 
reflects the atherosclerotic burden, endothelial dysfunction, and target organ damage than age per se3–5.
Of interest, 54% of the studied patients exhibited normal carotid IMT (<0.9 mm) despite having advanced 
atherosclerosis of the coronary artery requiring surgical revascularization. This observation verifies that increased 
carotid IMT is not merely a part of the preclinical disease process of atherosclerosis but also subject to modulation 
by various stimuli on the carotid artery3. It also implies that carotid IMT has a prognostic significance beyond that 
of a surrogate marker of atheroma burden. Whether incorporation of carotid IMT to established risk prediction 
models would improve their accuracies on predicting outcome merits a further large-scale study.
This study has several limitations. First, this study is subject to limitations inherent to its retrospective nature. 
Second, we excluded patients who presented as emergency cases and those with carotid artery stenosis, as carotid 
IMT measurement was not feasible in these patients. Apart from the inability to measure the IMT, ICA stenosis 
is also an obvious risk factor of postoperative neurologic complications38, that would not fit the purpose of the 
current study. Third, we used a cutoff value of ≥0.9 mm, which was validated by a vast amount of literature39. 
However, various IMT values (≥1.11 mm, ≥1.25 mm) for the prediction of cardiovascular or cerebrovascular 
complications were used in the above-cited studies, which cannot be addressed in the current study without seri-
ously sacrificing the statistical power. Another limitation is a relatively small sample size, which was not enough 
to investigate the association of IMT with individual cardiovascular events. Thus, only a composite of cardiovas-
cular morbidity endpoints was compared between the two groups. Lastly, only short-term follow up records were 
included in the current study. Further studies regarding long-term follow up results will be needed.
Conclusion
In conclusion, this retrospective analysis firstly reveals that increased carotid IMT (≥0.9 mm) was independently 
associated with a 1.7-fold increased risk of a 30-day composite of cardiovascular morbidity endpoints in patients 
undergoing OPCAB, along with the preoperative requirement for RRT. Our results provide evidence suggest-
ing that routine assessment of preoperative carotid IMT may allow a more comprehensive risk stratification in 
patients undergoing OPCAB.
Data availability statement. Materials, data and associated protocols are available.
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